Howard Lim

7PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsImplementation science and evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 07, 2026
Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers.

|May 31, 2026
Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

|Oct 09, 2024
Three Versus Six Months of Adjuvant Oxaliplatin-Containing Chemotherapy for Patients With Stage III Colorectal Cancer: A Contemporary Real-World Analysis.

Tharani Krishnan, Emily Leung, Joao Paulo Solar Vasconcelos

|Aug 08, 2024
"I Just Assumed This Was Already Being Done": Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology.

Samantha Pollard, Morgan Ehman, Anna Hermansen

|Jan 25, 2021
Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment.

Cheryl Ho, Brandon Chan, David Cameron

Pageof 2

Frequent Collaborators

4 joint publications

Sharlene Gill

4 joint publications

Cheryl Ho

3 joint publications

Jonathan M Loree

3 joint publications

Dean A Regier